The Drug Enforcement Administration’s Final Rule on Theft and Significant Loss Reporting: We Can See More Clearly NowJanuary 1, 2006
The pharmacist in charge of Kilgoban Pharmacy is conducting a routine inventory. When comparing the actual on-hand quantity of schedule II drugs with a computergenerated printout of the theoretical count, the pharmacist finds that the oxycodone 40 mg. tablet counts do not match. In fact, the audit shows a possible shortage of about 100 tablets. The pharmacist knows that something has to be done; after all, a schedule II drug may be missing, but what?